Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.358 USD | -3.77% | -6.41% | -25.83% |
May. 15 | Lumos Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Transcript : Lumos Pharma, Inc., Q1 2024 Earnings Call, May 15, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.83% | 19.89M | |
+54.05% | 63.85B | |
-1.98% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+14.13% | 26.52B | |
-20.34% | 18.69B | |
+2.99% | 12.73B | |
+22.44% | 12.11B | |
+29.07% | 12.07B |
- Stock Market
- Equities
- LUMO Stock
- News Lumos Pharma, Inc.
- Lumos Pharma : HC Wainwright Adjusts Price Target on Lumos Pharma to $27 From $34, Maintains Buy Rating